Intracranial atherosclerotic disease mechanism indicates poor outcomes of thrombectomy in acute cerebral infarction with large vessel occlusion: A matched cohort study.

Intracranial atherosclerotic disease Large vessel occlusion Outcome Thrombectomy Thrombolysis

Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
13 Sep 2024
Historique:
received: 30 05 2024
revised: 08 09 2024
accepted: 09 09 2024
medline: 21 9 2024
pubmed: 21 9 2024
entrez: 20 9 2024
Statut: aheadofprint

Résumé

Thrombectomy is a standard treatment for acute large vessel occlusion (LVO); however, its effectiveness in treating LVO related to intracranial atherosclerosis disease (ICAD) remains uncertain. This study aimed to compare thrombectomy outcomes in ICAD-related and embolic LVO, focusing on patients with similar symptom severities upon hospital admission. This retrospective study was conducted at Jikei University Hospital and Jikei University Kashiwa Hospital between October 2017 and March 2023. Ischemic stroke patients with LVO who underwent thrombectomy were categorized into ICAD and embolism groups based on the occlusion mechanism. Groups were matched using National Institutes of Health Stroke Scale scores at the time of admission. A modified Rankin Scale score of 5 or 6 at 90 days after symptom onset was defined as a devastating outcome. The procedural outcomes and frequency of devastating outcomes were compared between the ICAD and embolism groups. The study included 33 matched pairs were included. The ICAD group showed lower rates of successful reperfusion (43 % vs. 82 %, p = 0.001), and longer procedural times (median 88 min vs. 50 min, p < 0.001) than the embolism group. The ICAD group had a significantly higher frequency of devastating outcomes than the non-ICAD group (39 % vs. 15 %, p = 0.027). Multivariate analysis identified ICAD as an independent factor associated with devastating outcomes (OR, 3.804; 95 % confidence interval (95 %CI), 1.148-12.603; p = 0.029). In thrombectomy therapy, reperfusion rates and outcomes are significantly worse in patients with ICAD-LVO than in patients with embolic LVO.

Sections du résumé

BACKGROUND BACKGROUND
Thrombectomy is a standard treatment for acute large vessel occlusion (LVO); however, its effectiveness in treating LVO related to intracranial atherosclerosis disease (ICAD) remains uncertain. This study aimed to compare thrombectomy outcomes in ICAD-related and embolic LVO, focusing on patients with similar symptom severities upon hospital admission.
METHODS METHODS
This retrospective study was conducted at Jikei University Hospital and Jikei University Kashiwa Hospital between October 2017 and March 2023. Ischemic stroke patients with LVO who underwent thrombectomy were categorized into ICAD and embolism groups based on the occlusion mechanism. Groups were matched using National Institutes of Health Stroke Scale scores at the time of admission. A modified Rankin Scale score of 5 or 6 at 90 days after symptom onset was defined as a devastating outcome. The procedural outcomes and frequency of devastating outcomes were compared between the ICAD and embolism groups.
RESULTS RESULTS
The study included 33 matched pairs were included. The ICAD group showed lower rates of successful reperfusion (43 % vs. 82 %, p = 0.001), and longer procedural times (median 88 min vs. 50 min, p < 0.001) than the embolism group. The ICAD group had a significantly higher frequency of devastating outcomes than the non-ICAD group (39 % vs. 15 %, p = 0.027). Multivariate analysis identified ICAD as an independent factor associated with devastating outcomes (OR, 3.804; 95 % confidence interval (95 %CI), 1.148-12.603; p = 0.029).
CONCLUSION CONCLUSIONS
In thrombectomy therapy, reperfusion rates and outcomes are significantly worse in patients with ICAD-LVO than in patients with embolic LVO.

Identifiants

pubmed: 39303349
pii: S0022-510X(24)00370-8
doi: 10.1016/j.jns.2024.123235
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123235

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no financial conflicts of interest or personal relationships that may affect the work presented in this paper.

Auteurs

Ryoji Nakada (R)

Department of Neurology, The Jikei University Kashiwa Hospital, Chiba, Japan. Electronic address: ryoji2464@gmail.com.

Kenichi Sakuta (K)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: ryoji2464@gmail.com.

Takeo Sato (T)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Motohiro Okumura (M)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Hiroyuki Kida (H)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Sumire Yamamoto (S)

Department of Neurology, The Jikei University Kashiwa Hospital, Chiba, Japan.

Junichiro Takahashi (J)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Tomomichi Kitagawa (T)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Hiroki Takatsu (H)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Shinji Miyagawa (S)

Department of Neurology, The Jikei University Kashiwa Hospital, Chiba, Japan.

Teppei Komatsu (T)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Kenichiro Sakai (K)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Hidetaka Mitsumura (H)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Hiroshi Yaguchi (H)

Department of Neurology, The Jikei University Kashiwa Hospital, Chiba, Japan.

Yasuyuki Iguchi (Y)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Classifications MeSH